Changes to the instructions for medical use of medicinal products

Professional development Vacancies
Changes to the instructions for medical use of medicinal products
Flixonase™ (fluticasone propionate)

MoH of Ukraine order No. 771 of 02.09.13 approved the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product that…

Read more
Cipramil (citalopram)

MoH of Ukraine order No. 771 of 02.09.13 approved the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product that…

Read more
Rispolept® (risperidone)

MoH of Ukraine order No. 771 of 02.09.13 approved the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product that…

Read more
Pariet® (rabeprazole)

MoH of Ukraine order No. 752 of 23.08.13 approved the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product that…

Read more
Klacid® (clarithromycin)

Наказами МОЗ України № 615 від 18.07.13. та № 727 від 16.08.13р. було затверджено інструкції для медичного застосування (далі –…

Read more
Retrovir™ (zidovudine)

MoH order No. 727 of 16.08.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Endoxan® (cyclophosphamide)

MoH order No. 727 of 16.08.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Nexium (esomeprazole)

MoH order No. 727 of 16.08.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Myfortic (mycophenolic acid)

MoH order No. 712 of 09.08.13 approved the instruction for medical use (hereinafter, the instruction) of an original (reference) medicinal product that…

Read more
Zyprexa® Zydis (olanzapine)

By Order of the Ministry of Health of Ukraine No. 649 of 26.07.13, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product were approved,…

Read more